学术探索
学术期刊
新闻热点
数据分析
智能评审

THE DEVELOPMENT OF TAMOXIFEN FOR BREAST-CANCER THERAPY - A TRIBUTE TO THE LATE WALPOLE,ARTHUR L

被引：119
作者：
JORDAN, VC [1 ]
机构：
[1] UNIV WISCONSIN, DEPT PHARMACOL, MADISON, WI 53792 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1988年 / 11卷 / 03期
关键词：
D O I：
10.1007/BF01807278
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：197 / 209
页数：13
相关论文
共 144 条
[31]   ESTRADIOL RECEPTORS IN CARCINOMA AND BENIGN DISEASE OF BREAST - IN-VITRO ASSAY [J].
FEHERTY, P ;
FARRERBR.G ;
KELLIE, AE .
BRITISH JOURNAL OF CANCER, 1971, 25 (04) :697-&
[32]   INFLUENCE OF TUMOR ESTROGEN AND PROGESTERONE-RECEPTOR LEVELS ON THE RESPONSE TO TAMOXIFEN AND CHEMOTHERAPY IN PRIMARY BREAST-CANCER [J].
FISHER, B ;
REDMOND, C ;
BROWN, A ;
WICKERHAM, DL ;
WOLMARK, N ;
ALLEGRA, J ;
ESCHER, G ;
LIPPMAN, M ;
SAVLOV, E ;
WITTLIFF, J ;
FISHER, ER ;
PLOTKIN, D ;
BOWMAN, D ;
WOLTER, J ;
BORNSTEIN, R ;
DESSER, R ;
FRELICK, R .
JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (04) :227-241
[33]   ADJUVANT CHEMOTHERAPY WITH AND WITHOUT TAMOXIFEN IN THE TREATMENT OF PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT TRIAL [J].
FISHER, B ;
REDMOND, C ;
BROWN, A ;
FISHER, ER ;
WOLMARK, N ;
BOWMAN, D ;
PLOTKIN, D ;
WOLTER, J ;
BORNSTEIN, R ;
LEGAULTPOISSON, S ;
SAFFER, EA .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :459-471
[34]   1-PHENYLALANINE MUSTARD (L-PAM) IN MANAGEMENT OF PRIMARY BREAST-CANCER - REPORT OF EARLY FINDINGS [J].
FISHER, B ;
CARBONE, P ;
ECONOMOU, SG ;
FRELICK, R ;
GLASS, A ;
LERNER, H ;
REDMOND, C ;
ZELEN, M ;
BAND, P ;
KATRYCH, DL ;
WOLMARK, N ;
FISHER, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (03) :117-122
[35]   PROLONGING TAMOXIFEN THERAPY FOR PRIMARY BREAST-CANCER - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT CLINICAL-TRIAL [J].
FISHER, B ;
BROWN, A ;
WOLMARK, N ;
REDMOND, C ;
WICKERHAM, DL ;
WITTLIFF, J ;
DIMITROV, N ;
LEGAULTPOISSON, S ;
SCHIPPER, H ;
PRAGER, D .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (05) :649-654
[36]   TREATMENT OF PRIMARY BREAST-CANCER WITH CHEMOTHERAPY AND TAMOXIFEN [J].
FISHER, B ;
REDMOND, C ;
BROWN, A ;
WOLMARK, N ;
WITTLIFF, J ;
FISHER, ER ;
PLOTKIN, D ;
BOWMAN, D ;
SACHS, S ;
WOLTER, J ;
FRELICK, R ;
DESSER, R ;
LICALZI, N ;
GEGGIE, P ;
CAMPBELL, T ;
ELIAS, EG ;
PRAGER, D ;
KOONTZ, P ;
VOLK, H ;
DIMITROV, N ;
GARDNER, B ;
LERNER, H ;
SHIBATA, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (01) :1-6
[37]  
Fisher B, 1986, NCI Monogr, P35
[38]  
FOSTER BJ, 1986, CANCER TREAT REP, V70, P1003
[39]   METABOLISM OF TAMOXIFEN (ICI 46,474) .1. LABORATORY-ANIMALS [J].
FROMSON, JM ;
PEARSON, S ;
BRAMAH, S .
XENOBIOTICA, 1973, 3 (11) :693-709
[40]   METABOLISM OF TAMOXIFEN (ICI 46,474) .2. FEMALE PATIENTS [J].
FROMSON, JM ;
PEARSON, S ;
BRAMAH, S .
XENOBIOTICA, 1973, 3 (11) :711-714
12345678910